The case for a new approach for documenting platelet viability

Transfusion

Volumn 46, Issue SUPPL. 3, 2006, Pages

  Murphy, Scott ^a   AuBuchon, James P ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51;

CELL FUNCTION; CELL VIABILITY; HUMAN; ISOTOPE LABELING; REVIEW; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

EID: 33750482892     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.01019.x     Document Type: Review

References (21)

1. Aas KA, Gardner FH. Survival of blood platelets labeled with chromium. J Clin Invest 1958;37:1257-68.
2. Heaton WA, Davis HH, Welch MJ, et al. Indium-111: a new radionuclide label for studying human platelet kinetics. Br J Haematol 1979;42:613-22.
3. Taylor HL, Whitley P, Heaton A. A historical perspective on platelet radiolabeling techniques. Transfusion 2006;46(Suppl):53S-8S.
4. Aster RH, Jandl JH. Platelet sequestration in man. I. Methods. J Clin Invest 1964;43:843-55.
5. Aster RH. Pooling of platelets in the spleen. role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-57.
6. Murphy S, Gardner FH. Platelet preservation. Effect of storage temperature on maintenance of platelet viability - deleterious effect of refrigerated storage. N Engl J Med 1969;180:1094-8.
7. Simon TL, Nelson EJ, Carmen R, Murphy S. Extension of platelet concentrate storage. Transfusion 1983;23:207-12.
8. Holme S, Vaidja K, Murphy S. Platelet storage at 22°C: effect of type of agitation on morphology, viability and function in vitro. Blood 1978;52:425-35.
9. Murphy S, Holme S, Nelson E, Carmen R. Paired comparison of the in vivo and in vitro results of storage of platelet concentrates in two containers. Transfusion 1984;24:31-4.
10. Murphy S. Radiolabeling of PLTs to assess viability: a proposal for a standard. Transfusion 2004;44:131-3.
11. Holme S. Storage and quality assessment of platelets. Vox Sang 1998;74(Suppl 2):207-1611.
12. Lotter MG, Rab WL, Van Zyl JM, et al. A computer program in compiled BASIC for the IBM personal computer to calculate the mean platelet survival time with the multiple-hit and weighted mean methods. Comput Biol Med 1988;18:305-15.
13. Keegan T, Heaton A, Holme S, et al. Paired comparison of platelet concentrates prepared from platelet-rich-plasma and buffy coats using a new technique with 111In and 51Cr. Transfusion 1992;32:113-20.
14. 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol 1993;84:717-23.
15. AuBuchon JP, Herschel L, Roger J. Further investigation of use of radiolabeling studies to document platelet efficacy. Transfusion 2004;44(9S):28A.
16. Freireich EJ, Kliman A, Lawrence AG, Mantel N, Frei E. Response to repeated platelet transfusion from the same donor. Ann Intern Med 1963;59:277-87.
17. Arnold DM, Heddle NM, Carruthers J, et al. A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets. Transfusion 2004;44(9S):1A.
18. Sweeney JD, Holme S, Heaton WA, Nelson E. White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma. Transfusion 2000;40:615-6.
19. Sweeney JD, Holme S, Stromberg RR, Heaton WA. In vitro and in vivo effects of prestorage filtration of apheresis platelets. Transfusion 1995;35:125-30.
20. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
21. Dumont LJ. Analysis and reporting of platelet kinetic studies. Transfusion 2006;46(Suppl):67S-73S.